An	O
evolutionary	B:C1260118
conserved	I:C1260118
Hexim1	I:C1260118
peptide	I:C1260118
binds	B:C1167622
to	O
the	O
Cdk9	B:C0254251
catalytic	O
site	O
to	O
inhibit	O
P	B:C0663446
-	I:C0663446
TEFb	I:C0663446

The	O
positive	B:C0663446
transcription	I:C0663446
elongation	I:C0663446
factor	I:C0663446
(	O
P	B:C0663446
-	I:C0663446
TEFb	I:C0663446
)	O
is	O
required	O
for	O
the	O
transcription	B:C0040649
of	O
most	O
genes	B:C0017337
by	O
RNA	B:C0035679
polymerase	I:C0035679
II	I:C0035679
.	O

Hexim	B:C1260118
proteins	I:C1260118
associated	O
with	O
7SK	O
RNA	O
bind	O
to	O
P	B:C0663446
-	I:C0663446
TEFb	I:C0663446
and	O
reversibly	O
inhibit	O
its	O
activity	O
.	O

P-	B:C0663446
TEFb	I:C0663446
comprises	O
the	O
Cdk9	B:C0254251
cyclin-	B:C0243045
dependent	I:C0243045
kinase	I:C0243045
and	O
a	O
cyclin	B:C2717923
T.	I:C2717923
Hexim	B:C1260118
proteins	I:C1260118
have	O
been	O
shown	O
to	O
bind	B:C1167622
the	O
cyclin	B:C2717923
T	I:C2717923
subunit	O
of	O
P	B:C0663446
-	I:C0663446
TEFb	I:C0663446
.	O

How	O
this	O
binding	B:C1167622
leads	O
to	O
inhibition	O
of	O
the	O
kinase	B:C1150423
activity	I:C1150423
of	O
Cdk9	B:C0254251
has	O
remained	B:C0243095
elusive	I:C0243095
,	O
however	O
.	O

Using	O
a	O
photoreactive	B:C0002520
amino	I:C0002520
acid	I:C0002520
incorporated	O
into	O
proteins	B:C0033684
,	O
we	O
show	O
that	O
in	O
live	B:C0007634
cells	I:C0007634
,	O
cell	B:C0007592
extracts	I:C0007592
,	O
and	O
in	O
vitro	O
reconstituted	B:C1704241
complexes	I:C1704241
,	O
Hexim1	B:C1260118
cross-links	O
and	O
thus	O
contacts	O
Cdk9	B:C0254251
.	O

Notably	O
,	O
replacement	O
of	O
a	O
phenylalanine	B:C0031453
,	O
F208	B:C0002520
,	O
belonging	O
to	O
an	O
evolutionary	B:C1260118
conserved	I:C1260118
Hexim1	I:C1260118
peptide	I:C1260118
(	O
(	O
202	O
)	O
PYNTTQFLM	B:C0002518
(	O
210	O
)	O
)	O
known	O
as	O
the	O
"	B:C0002518
PYNT	I:C0002518
"	I:C0002518
sequence	I:C0002518
,	O
cross	O
-	O
links	O
a	O
peptide	B:C0030956
within	O
the	O
activation	O
segment	O
that	O
controls	O
access	B:C0444454
to	O
the	O
Cdk9	B:C0254251
catalytic	O
cleft	O
.	O

Reciprocally	O
,	O
Hexim1	B:C1260118
is	O
cross-linked	O
by	O
a	O
photoreactive	B:C0002520
amino	I:C0002520
acid	I:C0002520
replacing	O
Cdk9	B:C0254251
W193	I:C0254251
,	O
a	O
tryptophan	B:C0041249
within	O
this	O
activation	O
segment	O
.	O

These	O
findings	O
provide	O
evidence	O
of	O
a	O
direct	B:C0872079
interaction	I:C0872079
between	O
Cdk9	B:C0254251
and	O
its	O
inhibitor	B:C1449702
,	O
Hexim1	B:C1260118
.	O

Based	O
on	O
similarities	O
with	O
Cdk2	B:C0108855
3D	B:C0678594
structure	I:C0678594
,	O
the	O
Cdk9	B:C0254251
peptide	I:C0254251
cross-linked	O
by	O
Hexim1	B:C1260118
corresponds	O
to	O
the	O
substrate	B:C0005456
binding	I:C0005456
-	I:C0005456
site	I:C0005456
.	O

Accordingly	O
,	O
the	O
Hexim1	B:C1260118
PYNT	B:C0002518
sequence	I:C0002518
is	O
proposed	O
to	O
interfere	O
with	O
substrate	B:C0033618
binding	I:C0033618
to	O
Cdk9	B:C0254251
and	O
thereby	O
to	O
inhibit	O
its	O
kinase	B:C1150423
activity	I:C1150423
.	O

